The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

MEDNAX Inc

NYSE: MD
Last

(U.S.) $71.37

Today's change+0.28 +0.39%
Updated May 22 4:04 PM EDT. Delayed by at least 15 minutes.
 

MEDNAX Inc

NYSE: MD
Last

(U.S.) $71.37

Today's change+0.28 +0.39%
Updated May 22 4:04 PM EDT. Delayed by at least 15 minutes.

MEDNAX Inc crosses above 20-day moving average

MEDNAX Inc closed up Friday by (U.S.)$0.28 or 0.39% to (U.S.)$71.37 and crossing above its 20-day moving average. Over the last five days, shares have gained 1.38% and are currently 4.29% off of the 52-week high. Shares have outperformed the S&P 500 by 13.20% during the last year.

Key company metrics

  • Open(U.S.) $71.26
  • Previous close(U.S.) $71.09
  • High(U.S.) $72.15
  • Low(U.S.) $70.79
  • Bid / Ask-- / --
  • YTD % change+7.96%
  • Volume372,243
  • Average volume (10-day)584,770
  • Average volume (1-month)579,410
  • Average volume (3-month)542,181
  • 52-week range(U.S.) $49.82 to (U.S.) $74.57
  • Beta0.76
  • Trailing P/E21.86×
  • P/E 1 year forward19.94×
  • Forward PEG1.46×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.27
Updated May 22 4:04 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.82%

Based on its net profit margin of 12.82%, MEDNAX Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.02%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue639651627596
Total other revenue--------
Total revenue639651627596
Gross profit196223210201
Total cost of revenue443428416395
Total operating expense525509488466
Selling / general / administrative68686161
Research & development--------
Depreciation / amortization14141110
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income115141138130
Interest income (expense), net non-operating-3-3-2-2
Gain (loss) on sale of assets--------
Other--------
Income before tax113139137128
Income after tax69888679
Income tax, total44515149
Net income69888679
Total adjustments to net income--------
Net income before extra. items69888679
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items69888679
Inc. avail. to common incl. extra. items69888679
Diluted net income69888679
Dilution adjustment--------
Diluted weighted average shares9599100100
Diluted EPS excluding extraordinary itemsvalue per share0.720.890.860.79
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.720.890.860.79